Trial intelligence / Profile preview

Atosiban for IVF-embryo transfer outcomes

ChiCTR1900022333Phase 4Completed

Sponsor
Northwest Women's and Children's Hospital
Start
Apr 2019
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised trial of atosiban in infertility (2 arms), sponsored by Northwest Women's and Children's Hospital. Primary endpoint: Live birth rate. Started Apr 2019; status: completed.

02

Drugs

atosiban
03

Conditions

infertility

Beyond the preview

Go deeper on ChiCTR1900022333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call